Association of statins and nivolumab activity in patients with metastatic renal cell carcinoma (mRCC): Results from the phase II nivoren-GETUG AFU 26 trial.

被引：0
|
作者：
Colomba, Emeline [1 ]
Flippot, Ronan [2 ]
Dalban, Cecile [3 ]
Negrier, Sylvie [4 ]
Chevreau, Christine [5 ]
Gravis, Gwenaelle [6 ]
Oudard, Stephane [7 ]
Laguerre, Brigitte [8 ]
Barthelemy, Philippe [9 ]
Goupil, Marine Gross [10 ]
Geoffrois, Lionnel [11 ]
Rolland, Frederic [12 ]
Thiery-Vuillemin, Antoine [13 ]
Joly, Florence [14 ]
Ladoire, Sylvain [15 ]
Tantot, Florence [16 ]
Escudier, Bernard [17 ]
Albiges, Laurence [18 ]
机构：
[1] Paris Saclay Univ, Gustave Roussy Canc Campus, Villejuif, France
[2] Gustave Roussy, Dept Med Oncol, Villejuif, France
[3] Ctr Leon Berard, Lyon, France
[4] Ctr Leon Berard, Dept Med Oncol, Lyon, France
[5] IUCT Oncopole Inst Claudius Regaud, Toulouse, France
[6] Aix Marseille Univ, Inst Paoli Calmettes, Marseille, France
[7] Univ Paris, Hop Europeen Georges Pompidou, AP HP, Dept Oncol, Paris, France
[8] Ctr Eugene Marquis, Rennes, France
[9] Inst Cancerol Strasbourg Europe, Strasbourg, France
[10] CHU Bordeaux, Bordeaux, France
[11] Ctr Alexis Vautrin, Vandoeuvre Les Nancy, France
[12] Inst Cancerol Ouest, Dept Med Oncol, St Herblain, France
[13] Univ Hosp Jean Minjoz, Besancon, France
[14] Ctr Francois Baclesse, Dept Med Oncol, Caen, France
[15] Georges Francois Leclerc Canc Ctr, Dijon, France
[16] UNICANCER, Le Kremlin Bicetre, France
[17] Gustave Roussy, Villejuif, France
[18] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 06期
关键词：
D O I：
10.1200/JCO.2021.39.6_suppl.359
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
359
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Primary tumour response in patients treated with nivolumab for metastatic renal cell carcinoma (mRCC): Results of the GETUG-AFU 26 NIVOREN trial
    Courcier, J.
    Dalban, C.
    Laguerre, B.
    Ladoire, S.
    Barthelemy, P.
    Oudard, S.
    Joly, F.
    Mescam, G. Gravis
    Chevreau, C. M.
    Geoffrois, L.
    Deluche, E.
    Rolland, F.
    Topart, D.
    Culine, S.
    Negrier, S.
    Mahammedi, H.
    Tantot, F.
    Escudier, B.
    Flippot, R.
    Albiges, L.
    ANNALS OF ONCOLOGY, 2020, 31 : S560 - S560
  • [2] Safety and efficacy of nivolumab in metastatic renal cell carcinoma (mRCC): Results from the NIVOREN GETUG-AFU 26 study.
    Albiges, Laurence
    Negrier, Sylvie
    Dalban, Cecile
    Gravis, Gwenaelle
    Chevreau, Christine
    Oudard, Stephane
    Laguerre, Brigitte
    Barthelemy, Philippe
    Borchiellini, Delphine
    Gross-Goupil, Marine
    Geoffrois, Lionnel
    Brihoum, Meryem
    Escudier, Bernard
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [3] Association of adrenal metastases with outcomes in patients with metastatic clear cell renal cell carcinoma (mccRCC) treated with nivolumab in the GETUG-AFU-26 NIVOREN phase II trial.
    Billon, Emilien
    Dalban, Cecile
    Oudard, Stephane
    Chevreau, Christine
    Laguerre, Brigitte
    Barthelemy, Philippe
    Borchiellini, Delphine
    Geoffrois, Lionnel
    Negrier, Sylvie
    Joly, Florence
    Thiery-Vuillemin, Antoine
    Gross-Goupil, Marine
    Rolland, Frederic
    Priou, Frank
    Mahammedi, Hakim
    Tantot, Florence
    Escudier, Bernard
    Chabaud, Sylvie
    Albiges, Laurence
    Gravis, Gwenaelle
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [4] Is body mass index (BMI) associated with favorable outcomes in metastatic renal cell carcinoma (mRCC) treated with nivolumab? An ancillary study of the NIVOREN-GETUG AFU-26 trial
    Colomba, Emeline
    Dalban, Cecile
    Flechon, Aude
    Chevreau, Christine
    Gravis, Gwenaelle
    Thibault, Constance
    Laguerre, Brigitte
    Barthelemy, Philippe
    Borchiellini, Delphine
    Goupil, Marine Gross
    Geoffrois, Lionnel
    Rolland, Frederic
    Thiery-Vuillemin, Antoine
    Joly, Florence
    Ladoire, Sylvain
    Tantot, Florence
    Escudier, Bernard
    Albiges, Laurence
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [5] Primary Renal Tumour Response in Patients Treated with Nivolumab for Metastatic Renal Cell Carcinoma: Results from the GETUG-AFU 26 NIVOREN Trial
    Courcier, Jean
    Dalban, Cecile
    Laguerre, Brigitte
    Ladoire, Sylvain
    Barthelemy, Philippe
    Oudard, Stephane
    Joly, Florence
    Gravis, Gwenaelle
    Chevreau, Christine
    Geoffrois, Lionel
    Deluche, Elise
    Rolland, Frederic
    Topart, Delphine
    Culine, Stephane
    Negrier, Sylvie
    Mahammedi, Hakim
    Tantot, Florence
    Jamet, Antoine
    Escudier, Bernard
    Flippot, Ronan
    Albiges, Laurence
    EUROPEAN UROLOGY, 2021, 80 (03) : 325 - 329
  • [6] Efficacy and safety of nivolumab in patients with metastatic renal cell carcinoma (mRCC) and brain metastases: Preliminary results from the GETUG-AFU 26 (Nivoren) study.
    Escudier, Bernard J.
    Chabaud, Sylvie
    Borchiellini, Delphine
    Gravis, Gwenaelle
    Chevreau, Christine
    Brachet, Pierre Emmanuel
    Geoffrois, Lionnel
    Laguerre, Brigitte
    Mahammedi, Hakim
    Negrier, Sylvie
    Rolland, Frederic
    Goupil, Marine Gross
    Habibian, Muriel
    Albiges, Laurence
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [7] Antibiotic (ATB) therapy and outcome from nivolumab (N) in metastatic renal cell carcinoma (mRCC) patients (pts): Results of the GETUG-AFU 26 NIVOREN multicentric phase II study
    Derosa, L.
    Silva, C. Alves Costa
    Dalban, C.
    Colomba, E.
    Negrier, S.
    Chevreau, C. M.
    Gravis, G.
    Oudard, S. M.
    Laguerre, B.
    Barthelemy, P.
    Borchiellini, D.
    Gross-Goupil, M.
    Geoffrois, L.
    Rolland, F.
    Thiery-Vuillemin, A.
    Joly, F.
    Ladoire, S.
    Tantot, F.
    Escudier, B.
    Albiges, L.
    ANNALS OF ONCOLOGY, 2021, 32 : S681 - S681
  • [8] Safety and efficacy of nivolumab in metastatic renal cell carcinoma (mRCC): Final analysis from the NIVOREN GETUG AFU 26 study.
    Albiges, Laurence
    Negrier, Sylvie
    Dalban, Cecile
    Chevreau, Christine
    Gravis, Gwenaelle
    Oudard, Stephane
    Laguerre, Brigitte
    Barthelemy, Philippe
    Borchiellini, Delphine
    Gross-Goupil, Marine
    Geoffrois, Lionnel
    Rolland, Frederic
    Thiery-Vuillemin, Antoine
    Joly, Florence
    Ladoire, Sylvain
    Tantot, Florence
    Escudier, Bernard
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [9] Efficacy and safety of nivolumab in renal cell carcinoma patients with BONE metastases: Results of the GETUG: AFU 26 nivoren multicenter phase II study.
    Velev, Maud
    Dalban, Cecile
    Chevreau, Christine
    Gravis, Gwenaelle
    Negrier, Sylvie
    Laguerre, Brigitte
    Gross-Goupil, Marine
    Ladoire, Sylvain
    Ferrari, Victoria
    Geoffrois, Lionnel
    Curcio, Hubert
    Priou, Frank
    Thomas, Quentin Dominique
    Mione, Cecile
    Barthelemy, Philippe
    Tantot, Florence
    Escudier, Bernard
    Chabaud, Sylvie
    Albiges, Laurence
    Thibault, Constance
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [10] Prognosis impact of serous metastases (SMs) in clear cell renal cell carcinoma patients in the GETUG-AFU-26 NIVOREN phase II trial.
    Bardet, Florian
    Dalban, Cecile
    Chevreau, Christine
    Negrier, Sylvie
    Laguerre, Brigitte
    Gravis, Gwenaelle
    Gross-Goupil, Marine
    Oudard, Stephane
    Barthelemy, Philippe
    Ferrero, Jean Marc
    Thiery-Vuillemin, Antoine
    Mahammedi, Hakim
    Narciso, Berangere
    Geoffrois, Lionnel
    Tantot, Florence
    Escudier, Bernard
    Ladoire, Sylvain
    Albiges, Laurence
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345